IMMUNISBIO Co.
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $4M
Investors
- 3
About IMMUNISBIO Co.
, Ltd. operates as a cell therapy development company that is focused on the development of immune cell therapy such as immune cell therapy, functional cosmetics, culture automation, and technology export, with the goal of curing cancer-related diseases., Ltd.
Who invested in IMMUNISBIO Co.
3 investors across 1 round
See all investors in IMMUNISBIO Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 1, 2021
Amount
$4M
Investors
Questions about IMMUNISBIO Co.
Who invested in IMMUNISBIO Co.?
IMMUNISBIO Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMMUNISBIO Co. raised?
IMMUNISBIO Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IMMUNISBIO Co. last raise money?
IMMUNISBIO Co.'s most recent round on record is a Series B, in Feb 2021.
What does IMMUNISBIO Co. do?
IMMUNISBIO Co. is a biotechnology company.
Where is IMMUNISBIO Co. headquartered?
IMMUNISBIO Co. is headquartered in Incheon, South Korea.
Which VCs invest in companies like IMMUNISBIO Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at IMMUNISBIO Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like IMMUNISBIO Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.